← Back to Search

Photoacoustic Imaging for Breast Cancer

N/A
Recruiting
Led By Ermelinda Bonaccio
Research Sponsored by Roswell Park Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women with clinically suspicious or confirmed breast cancer masses (that have not been surgically removed) and will/have already undergo/undergone breast magnetic resonance imaging (MRI).
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights

Study Summary

This trial is testing a new way to image breasts, which may be especially helpful for women with dense breasts.

Who is the study for?
This trial is for women with suspected or confirmed breast cancer who have not had the mass surgically removed and have undergone or will undergo an MRI. It excludes non-English speakers, prisoners, minors, pregnant women (to avoid unknown risks), those with recent breast implants, and adults unable to consent.Check my eligibility
What is being tested?
The study is testing photoacoustic imaging on the breast tissue of both healthy subjects and patients with breast cancer. This technique combines light and sound to potentially improve detection in dense breasts where mammography may be less sensitive.See study design
What are the potential side effects?
There are no direct benefits from participating in this study; however, there are also no known significant side effects associated with photoacoustic imaging as it's a non-invasive procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a breast mass that hasn't been removed and will/have had a breast MRI.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Identify photoacoustic features of breast malignancies

Trial Design

1Treatment groups
Experimental Treatment
Group I: Diagnostic (photoacoustic imaging of the breast)Experimental Treatment1 Intervention
Participants undergo photoacoustic imaging of the breast over 30 minutes. At subject's discretion, imaging may repeat for a total of 10 studies, each in a separate day.

Find a Location

Who is running the clinical trial?

Susan G. Komen Breast Cancer FoundationOTHER
65 Previous Clinical Trials
216,988 Total Patients Enrolled
41 Trials studying Breast Cancer
215,072 Patients Enrolled for Breast Cancer
Roswell Park Cancer InstituteLead Sponsor
400 Previous Clinical Trials
30,599 Total Patients Enrolled
10 Trials studying Breast Cancer
1,638 Patients Enrolled for Breast Cancer
Ermelinda BonaccioPrincipal InvestigatorRoswell Park Cancer Institute

Media Library

Photoacoustic Imaging Clinical Trial Eligibility Overview. Trial Name: NCT03897270 — N/A
Breast Cancer Research Study Groups: Diagnostic (photoacoustic imaging of the breast)
Breast Cancer Clinical Trial 2023: Photoacoustic Imaging Highlights & Side Effects. Trial Name: NCT03897270 — N/A
Photoacoustic Imaging 2023 Treatment Timeline for Medical Study. Trial Name: NCT03897270 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers currently enrolling participants in this medical trial?

"Affirmative. According to the clinical trial registry, this ongoing medical research is actively seeking participants that can be found on clinicaltrials.gov since October 18th 2018 and was most recently modified in March 25th 2022. A total of 220 volunteers are sought at a single location."

Answered by AI

What is the current size of this research endeavor?

"Affirmative. The digital archives of clinicaltrials.gov confirm that this scientific research program, which was first advertised on October 18th 2018, is actively seeking participants. 220 individuals are required from a single centre for participation in the study."

Answered by AI

Who else is applying?

What state do they live in?
New York
What site did they apply to?
Roswell Park Cancer Institute
What portion of applicants met pre-screening criteria?
Met criteria
~6 spots leftby May 2024